Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer - Scorecard - MDSpire

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer

  • By

  • Su Zhang

  • Hanghao Zhang

  • Xingwang Dong

  • Zhen Qi

  • Yingjun Ma

  • Hong Chang

  • Ye Li

  • Wei Zhang

  • June 8, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Early Tumor Regression and Bladder Preservation Following Short-Term Immunotherapy in Two Patients with Bulky Muscle-Invasive Bladder Cancer

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingOncology, investigational treatment (clarify sourcing)

Key Highlights

  • Remove unsupported conclusions about patient outcomes.

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • '
    • m
    • a
    • y
    • b
    • e
    • c
    • o
    • n
    • s
    • i
    • d
    • e
    • r
    • e
    • d
    • '
    • u
    • n
    • l
    • e
    • s
    • s
    • d
    • i
    • r
    • e
    • c
    • t
    • l
    • y
    • s
    • o
    • u
    • r
    • c
    • e
    • d
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify sourcing.

        Clinical Best Practices

        • Ensure all practices are directly supported by the source.

        Related Resources & Content

        Original Source(s)

        Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer

        • by Su Zhang, Hanghao Zhang, Xingwang Dong, Zhen Qi, Yingjun Ma, Hong Chang, Ye Li, Wei Zhang

        • June 8, 2026

        Related Content

        First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study

        Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial

        Case report: A challenging case of stage IVB mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder treated with extended radical resection including portal vein reconstruction